🇺🇸 mometasone furoate nasal spray in United States

FDA authorised mometasone furoate nasal spray on 1 October 1997

Marketing authorisations

FDA — authorised 1 October 1997

  • Application: NDA020762
  • Marketing authorisation holder: ORGANON LLC
  • Local brand name: NASONEX
  • Indication: SPRAY, METERED — NASAL
  • Status: approved

Read official source →

FDA

  • Status: approved

mometasone furoate nasal spray in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is mometasone furoate nasal spray approved in United States?

Yes. FDA authorised it on 1 October 1997; FDA has authorised it.

Who is the marketing authorisation holder for mometasone furoate nasal spray in United States?

ORGANON LLC holds the US marketing authorisation.